FLEXASO
Dead / Abandoned — Abandoned — no statement of use filed (as of 16 Jun 2025)
What this means for you
This application is over — abandoned 16 Jun 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97607854
- Mark type
- Stylized text
- Filed
- 26 Sept 2022
- Published for opposition
- 17 Sept 2024
- Abandoned
- 16 Jun 2025
- Attorney of record
- Jessica L. Rothstein
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical research and development; research and development of pharmaceuticals and therapeutics to treat genetic and neurodegenerative diseases; research and development of pharmaceuticals and therapeutics which target the DNA of specific disease-related proteins and regulate the protein's amount and countering the diseased pathway; research and development of pharmaceuticals and therapeutics which target the RNA of specific disease-related proteins and regulate the protein's amount and countering the diseased pathway
Owner
- QurAlis Corporation, Cambridge, MA, US
- QurAlis Corporation, Cambridge, MA, US
Prosecution history
- 16 Jun 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 16 Jun 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 12 Nov 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 17 Sept 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Sept 2024 — PUBLISHED FOR OPPOSITION
- 28 Aug 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 13 Aug 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 08 Aug 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 08 Aug 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 06 Aug 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 11 Jul 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 11 Jul 2024 — NON-FINAL ACTION E-MAILED
- 11 Jul 2024 — NON-FINAL ACTION WRITTEN
- 08 Jul 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 08 Jul 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE